Cassidy Blocks O’Neill’s NSF Nomination Over Science Integrity Concerns

3 min read
Source: The Hill
Cassidy Blocks O’Neill’s NSF Nomination Over Science Integrity Concerns
Photo: The Hill
TL;DR

Senate HELP Committee Chair Bill Cassidy canceled a confirmation vote for Jim O’Neill, the Trump administration’s nominee for National Science Foundation (NSF) director. Cassidy stated O’Neill failed to defend scientific integrity during his tenure as acting CDC director and HHS deputy secretary. The move ends O’Neill’s bid to lead the agency before a Democratic-led Senate takes control in January, leaving the NSF under interim leadership.

Key points

  • Cassidy canceled the vote, stating O’Neill did not stand up against 'irresponsible decisions' by HHS Secretary Robert F. Kennedy Jr.
  • Cassidy cited O’Neill’s role in the 2025 firing of CDC director Susan Monarez as a concern regarding his independent judgment.
  • The NSF has lacked a Senate-confirmed leader since April 2025, when Sethuraman Panchanathan resigned amid funding cuts.
  • The White House withdrew the nomination of Heidi Overton for FDA commissioner just hours before the NSF vote, citing a lack of support.
  • NSF chief of staff Brian Stone is currently serving as acting director but plans to retire at the end of 2026.

Background

The NSF has been without a confirmed director since April 2025, following the resignation of Sethuraman Panchan amid efforts to cancel grants and slash funding. The agency is currently led by acting chief of staff Brian Stone, who announced plans to retire by year's end. This rejection occurs as the Republican-led Senate races to confirm nominees before losing its majority in January, a period marked by internal GOP conflicts over other judicial and administrative picks.

How outlets are covering it

The Hill and The Guardian report that Cassidy, a physician, expressed personal respect for O’Neill but deemed him unfit for the role due to his lack of fortitude against Kennedy’s policies. The Guardian notes that Cassidy had previously supported Heidi Overton’s FDA nomination but withdrew it after anti-abortion senators demanded assurances on abortion stances that the White House refused to provide. Politico highlights the broader context of the lame-duck session, where Republicans are attempting to finalize appointments before Democrats take control of the Senate in January, a process complicated by internal party divisions and procedural disputes.

Why it matters

The rejection leaves the National Science Foundation, a key agency for basic research funding, without a permanent leader as it faces significant budget cuts and grant freezes. The decision highlights deepening tensions between the Trump administration and Senate Republicans over public health and scientific integrity, particularly regarding vaccine policies and the firing of CDC officials. It also signals the fragility of the GOP’s ability to pass its preferred nominees before the January change in Senate leadership.

What to watch

The White House is expected to nominate a new candidate for the NSF directorship, though the timing may be constrained by the upcoming shift in Senate control. The agency will continue to operate under interim leadership, potentially with Brian Stone serving as acting director until his planned retirement at the end of 2026. The next nominee will face a Democratic-led Senate, which may scrutinize candidates more closely for their stances on scientific independence and public health policy.

Share this article

Want the full story? Read the original reporting

Read on The Hill